INTS insider filings
INTENSITY THERAPEUTICS, INC. — 33 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-07-20. Screen INTS transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for INTS between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — INTENSITY THERAPEUTICS, INC.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-20 | 4 | Donovan Daniel — Director | Grant/award (A): 5,500 (derivative) @ $0 | EDGAR |
| 2026-07-20 | 4 | Wesolowski John M — Principal Accounting Officer | Grant/award (A): 11,000 (derivative) @ $0 | EDGAR |
| 2026-07-20 | 4 | Leahy Emer — Director | Grant/award (A): 5,500 (derivative) @ $0 | EDGAR |
| 2026-07-20 | 4 | Talamo Joseph — Chief Financial Officer | Grant/award (A): 34,000 (derivative) @ $0 | EDGAR |
| 2026-07-20 | 4 | GOLDBERG MARK A — Director | Grant/award (A): 5,500 (derivative) @ $0 | EDGAR |
| 2026-07-20 | 4 | BENDER LEWIS H — President and CEO, Director | Grant/award (A): 78,000 (derivative) @ $0 | EDGAR |
| 2026-07-20 | 4 | DUBIN THOMAS I H — Director | Grant/award (A): 5,500 (derivative) @ $0 | EDGAR |
| 2026-07-01 | 4 | Wesolowski John M — Principal Accounting Officer | Grant/award (A): 3,688 @ $3.48 | EDGAR |
| 2026-07-01 | 4 | Talamo Joseph — Chief Financial Officer | Grant/award (A): 1,093 @ $3.48 | EDGAR |
| 2026-03-30 | 4 | BENDER LEWIS H — President and CEO, Director | Grant/award (A): 37,749 @ $6.11 | EDGAR |
| 2026-01-05 | 4 | Wesolowski John M — Principal Accounting Officer | Grant/award (A): 8,918 @ $0.26 | EDGAR |
| 2026-01-05 | 4 | Talamo Joseph — Chief Financial Officer | Grant/award (A): 14,482 @ $0.26 | EDGAR |
| 2025-07-02 | 4 | Wesolowski John M — Principal Accounting Officer | Grant/award (A): 69,745 @ $0.26 | EDGAR |
| 2025-07-02 | 4 | Talamo Joseph — Chief Financial Officer | Grant/award (A): 14,179 @ $0.26 | EDGAR |
| 2025-05-06 | 4 | Wesolowski John M — Principal Accounting Officer | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2025-05-06 | 4 | Donovan Daniel — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2025-05-06 | 4 | Leahy Emer — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2025-05-06 | 4 | Wesolowski John M — Principal Accounting Officer | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2025-05-06 | 4 | Talamo Joseph — Chief Financial Officer | Grant/award (A): 300,000 (derivative) @ $0 | EDGAR |
| 2025-05-06 | 4 | GOLDBERG MARK A — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2025-05-06 | 4 | BENDER LEWIS H — President and CEO, Director, 10% owner | Grant/award (A): 700,000 (derivative) @ $0 | EDGAR |
| 2025-05-06 | 4 | DUBIN THOMAS I H — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2024-10-23 | 4 | Wesolowski John M — Principal Accounting Officer | Grant/award (A): 70,028 (derivative) @ $0 | EDGAR |
| 2024-10-23 | 4 | Talamo Joseph — Chief Financial Officer | Grant/award (A): 427,379 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | Wesolowski John M — Principal Accounting Officer | Option exercise (M): 1,000 @ $4 · Option exercise (M): 1,000 (derivative) @ $0 | EDGAR |
| 2024-05-15 | 4 | DUBIN THOMAS I H — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2024-03-07 | 4 | Wesolowski John M — See Remarks | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2024-03-07 | 4 | Leahy Emer — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2024-03-07 | 4 | Donovan Daniel — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2024-03-07 | 4 | GOLDBERG MARK A — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2024-03-07 | 4 | BENDER LEWIS H — President and CEO, Director, 10% owner | Grant/award (A): 464,805 (derivative) @ $0 · Grant/award (A): 33,574 (derivative) @ $0 | EDGAR |
| 2023-12-12 | 4 | Talamo Joseph — Chief Financial Officer | Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
| 2023-07-21 | 4 | Wesolowski John M — Interim CFO | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — INTENSITY THERAPEUTICS, INC.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-11-05 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-11 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-16 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-05-07 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-27 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-23 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-06 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-05 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-13 | 8-K | 3.03 — Material Modification to Rights of Security Holders 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-12-05 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=INTS returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs